Pain Management News

• Alert EMA Says Don't Mix Mysimba and Opioid-Containing Meds Existing advice for prescribing the weight loss drugs needs to be strengthened to minimize the risks from interactions, the European drug authority said.
  Medscape Medical News, July 26, 2024
• Alert EU Backs Drug to Relieve Itching in Alagille Syndrome The European Medicines Agency said there were exceptional circumstances for approving Kayfanda to treat pruritus in patients with the rare genetic disorder.
  Medscape Medical News, July 26, 2024
• Alert Anzupgo Approved in Europe for Severe Hand Eczema The drug downregulates immune and inflammatory responses in cells linked to the disease pathology.
  Medscape Medical News, July 26, 2024
• Alert EMA Backs Oral Drug for Primary Biliary Cholangitis Iqirvo can delay liver fibrosis and cirrhosis in patients with primary biliary cholangitis, the European Medicines Agency decided.
  Medscape Medical News, July 26, 2024
• Tirbanibulin 1% Safe in Extensive Actinic Keratosis The safety and tolerability of tirbanibulin 1% in patients with actinic keratosis over a larger treatment field was confirmed in a phase 3 study.
  Medscape Medical News, July 26, 2024
• 'Doesn't Fit Anything I Trained for': Treating Chronic Lyme Researchers, clinicians, and patient advocates at a national meeting weighed in on efforts needed to accelerate research on treatments for chronic illness associated with Lyme disease.
  Medscape Medical News, July 26, 2024
• Inappropriate NSAID Prescribing Causing Avoidable Harm Prescribing NSAIDs to people at high risk of harm from them has cost more than 6000 years of good health and £31 million for the NHS over the past decade, a study found.
  Medscape News UK, July 26, 2024
• A Woman, a Tuna Steak, and Allergy-like Symptoms Scombroid poisoning resembles an allergic reaction and occurs after eating fish contaminated with histamine.
  Medscape News UK, July 26, 2024
• Slow-Release Buprenorphine Safe in Mild OUD Withdrawal Extended-release buprenorphine medication was deemed safe for patients with mild opioid withdrawal.
  Medscape Medical News, July 25, 2024
• EULAR 2024 Taper, Dose Down, Discontinue: Striving for Less Steroid Use Now in the 75th year since the first presentation on the clinical use of glucocorticoids, what consensus has been reached in sparing their use to avoid their many potential adverse effects?
  Medscape Medical News, July 25, 2024
• Baseline Bone Pain Predicts Survival in Mets Prostate Cancer Baseline bone pain was associated with worse survival outcomes in patients with metastatic hormone-sensitive prostate cancer, according to a recent post hoc analysis.
  Medscape Medical News, July 25, 2024
• Primary Care Meets Artificial Intelligence As artificial intelligence continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.
  Medscape Medical News, July 25, 2024
• Physicians Cite Barriers in Addiction Care: Study Reveals An international research review identifies multiple reasons why doctors say they aren't able to treat substance abuse, including lack of faith that interventions will work.
  Medscape Medical News, July 25, 2024
• Louisiana: Abortion Now Controlled Dangerous Substances Louisiana lawmakers have added mifepristone and misoprostol to the state's list of controlled dangerous substances.
  KFF Health News, July 25, 2024
• Delgocitinib Effective for Hand Eczema in Phase 3 Studies Topical delgocitinib was effective and well tolerated in patients with chronic hand eczema with no safety concerns.
  Medscape Medical News, July 23, 2024
• Accelerated Approval Pathway for Cancer Drugs: Does It Work? Experts expressed concern that the accelerated pathway for cancer drug approval may be overused and does not always effectively balance access and efficacy.
  Medscape Medical News, July 23, 2024
• Hemophilia: Novel Tx Also Cuts Bleeding in Kids New research shows that efanesoctocog alfa, a bioengineered factor VIII therapy, is effective and safe in preventing bleeding in children with severe hemophilia A.
  MDedge News, July 23, 2024
• How Drones May Narrow Emergency Response Times Starting in September, if someone in Clemmons, North Carolina, calls 911 to report a cardiac arrest, the first responder on the scene may be a drone.
  KFF Health News, July 23, 2024
• Atogepant May Prevent Rebound Headache From Med Overuse The CGRP atogepant is effective in preventing rebound headache related to medication overuse in patients with chronic migraine, new research suggested.
  Medscape Medical News, July 22, 2024
• Adjusting Opioid Prescriptions After ED Can Reduce Misuse Half of patients take five or fewer tablets in the 2 weeks after leaving the emergency department for a new pain condition, data suggest.
  Medscape Medical News, July 22, 2024